IL17A and hypertensive disorder: In the same study, after identification of elevated TH17 cells in both the gut and brain, neutralisation of IL-17a with antibodies decreased gut inflammation and neuroinflammation, in addition to preventing HTN development, suggesting a central aetiological role for IL-17a in OSA-induced HTN [120].